Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet

Chao Qin(University of Southern California), Lifang Yin(China Pharmaceutical University), Chunli Zhu, Guangji Wang(State Key Laboratory of Natural Medicine), Wei He(Howard Hughes Medical Institute), Jin Zhu(China Pharmaceutical University), Qiang Zhang(Peking University), Mengmeng Wu(Nankai University)
International Journal of Pharmaceutics
March 5, 2014
10.1016/j.ijpharm.2014.03.002
Cited by 37

Related Papers

Multifunctional nanoparticle-mediated combining therapy for human diseases
|Signal Transduction and Targeted Therapy|2024|461
High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance
|Nature Communications|2021|269
Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity
|Journal of Controlled Release|2015|254
Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells
|ACS Nano|2018|229
A Porous Au@Rh Bimetallic Core–Shell Nanostructure as an H<sub>2</sub>O<sub>2</sub>‐Driven Oxygenerator to Alleviate Tumor Hypoxia for Simultaneous Bimodal Imaging and Enhanced Photodynamic Therapy
|Advanced Materials|2020|216